Listed

Aura Biosciences, Inc.

AURANasdaqCIK 1501796HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$48.1m, Q2 FY2026
Net income−$45.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m15.4Research and development, Q3 FY2023, three months to 2023-09-30$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure20.3Research and development, Q4 FY2023, three months to 2023-12-31$20.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0000950170-25-043943. Derived: 12-month figure less the 9-month figure.Report this figure17.1Research and development, Q1 FY2024, three months to 2024-03-31$17.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure16.9Research and development, Q2 FY2024, three months to 2024-06-30$16.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure17.0Research and development, Q3 FY2024, three months to 2024-09-30$17.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure22.3Research and development, Q4 FY2024, three months to 2024-12-31$22.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure23.3Research and development, Q1 FY2025, three months to 2025-03-31$23.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure22.9Research and development, Q2 FY2025, three months to 2025-06-30$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure22.2Research and development, Q3 FY2025, three months to 2025-09-30$22.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure21.9Research and development, Q4 FY2025, three months to 2025-12-31$21.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure28.0Research and development, Q1 FY2026, three months to 2026-03-31$28.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure30.7Research and development, Q2 FY2026, three months to 2026-06-30$30.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Operating income$m(20.5)Operating income, Q3 FY2023, three months to 2023-09-30−$20.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure(24.8)Operating income, Q4 FY2023, three months to 2023-12-31−$24.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043943. Derived: 12-month figure less the 9-month figure.Report this figure(22.3)Operating income, Q1 FY2024, three months to 2024-03-31−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure(22.8)Operating income, Q2 FY2024, three months to 2024-06-30−$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure(23.2)Operating income, Q3 FY2024, three months to 2024-09-30−$23.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure(27.8)Operating income, Q4 FY2024, three months to 2024-12-31−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure(29.0)Operating income, Q1 FY2025, three months to 2025-03-31−$29.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(28.6)Operating income, Q2 FY2025, three months to 2025-06-30−$28.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure(27.9)Operating income, Q3 FY2025, three months to 2025-09-30−$27.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure(27.2)Operating income, Q4 FY2025, three months to 2025-12-31−$27.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure(34.9)Operating income, Q1 FY2026, three months to 2026-03-31−$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(48.1)Operating income, Q2 FY2026, three months to 2026-06-30−$48.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125428. Derived: 9-month figure less the 6-month figure.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$137.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-24, accession 0000950170-25-043943. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$46.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001193125-25-179426. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$43.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$24.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$18.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$48.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$26.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$29.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Net income$m(18.5)Net income, Q3 FY2023, three months to 2023-09-30−$18.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure(22.1)Net income, Q4 FY2023, three months to 2023-12-31−$22.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043943. Derived: 12-month figure less the 9-month figure.Report this figure(19.7)Net income, Q1 FY2024, three months to 2024-03-31−$19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure(20.3)Net income, Q2 FY2024, three months to 2024-06-30−$20.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure(21.0)Net income, Q3 FY2024, three months to 2024-09-30−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure(25.8)Net income, Q4 FY2024, three months to 2024-12-31−$25.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure(27.5)Net income, Q1 FY2025, three months to 2025-03-31−$27.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure(27.0)Net income, Q2 FY2025, three months to 2025-06-30−$27.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure(26.1)Net income, Q3 FY2025, three months to 2025-09-30−$26.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure(25.6)Net income, Q4 FY2025, three months to 2025-12-31−$25.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure(33.7)Net income, Q1 FY2026, three months to 2026-03-31−$33.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure(45.6)Net income, Q2 FY2026, three months to 2026-06-30−$45.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Diluted EPS$ per share(0.48)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figurenot reported(0.40)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure(0.41)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure(0.42)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figurenot reported(0.55)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(0.47)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure(0.40)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figurenot reported(0.50)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(0.48)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Basic EPS$ per share(0.48)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figurenot reported(0.40)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure(0.41)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure(0.42)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figurenot reported(0.55)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(0.47)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure(0.40)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figurenot reported(0.50)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(0.48)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure

Balance sheet

Cash and equivalents$67.8m, Q2 FY2026
Shareholders' equity$315.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m55.6Cash and equivalents, Q3 FY2023, at 2023-09-30$55.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure41.1Cash and equivalents, FY2023, at 2023-12-31$41.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0000950170-25-043943.Report this figure26.3Cash and equivalents, Q1 FY2024, at 2024-03-31$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure30.1Cash and equivalents, Q2 FY2024, at 2024-06-30$30.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure25.4Cash and equivalents, Q3 FY2024, at 2024-09-30$25.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure31.7Cash and equivalents, FY2024, at 2024-12-31$31.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001193125-26-130401.Report this figure38.2Cash and equivalents, Q1 FY2025, at 2025-03-31$38.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure107Cash and equivalents, Q2 FY2025, at 2025-06-30$107.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure47.6Cash and equivalents, Q3 FY2025, at 2025-09-30$47.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure59.5Cash and equivalents, FY2025, at 2025-12-31$59.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure84.8Cash and equivalents, Q1 FY2026, at 2026-03-31$84.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure67.8Cash and equivalents, Q2 FY2026, at 2026-06-30$67.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Current assets$m154Current assets, Q3 FY2023, at 2023-09-30$153.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062097.Report this figure232Current assets, FY2023, at 2023-12-31$231.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043943.Report this figure212Current assets, Q1 FY2024, at 2024-03-31$212.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056265.Report this figure196Current assets, Q2 FY2024, at 2024-06-30$195.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093308.Report this figure183Current assets, Q3 FY2024, at 2024-09-30$183.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure161Current assets, FY2024, at 2024-12-31$160.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130401.Report this figure135Current assets, Q1 FY2025, at 2025-03-31$134.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure184Current assets, Q2 FY2025, at 2025-06-30$184.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure170Current assets, Q3 FY2025, at 2025-09-30$170.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure150Current assets, FY2025, at 2025-12-31$149.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure119Current assets, Q1 FY2026, at 2026-03-31$118.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure329Current assets, Q2 FY2026, at 2026-06-30$329.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Total assets$m180Total assets, Q3 FY2023, at 2023-09-30$179.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062097.Report this figure255Total assets, FY2023, at 2023-12-31$255.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0000950170-25-043943.Report this figure235Total assets, Q1 FY2024, at 2024-03-31$235.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056265.Report this figure218Total assets, Q2 FY2024, at 2024-06-30$218.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093308.Report this figure205Total assets, Q3 FY2024, at 2024-09-30$205.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure183Total assets, FY2024, at 2024-12-31$182.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001193125-26-130401.Report this figure155Total assets, Q1 FY2025, at 2025-03-31$155.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure204Total assets, Q2 FY2025, at 2025-06-30$204.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure190Total assets, Q3 FY2025, at 2025-09-30$190.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure169Total assets, FY2025, at 2025-12-31$169.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure138Total assets, Q1 FY2026, at 2026-03-31$137.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure348Total assets, Q2 FY2026, at 2026-06-30$348.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Current liabilities$m10.9Current liabilities, Q3 FY2023, at 2023-09-30$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062097.Report this figure12.4Current liabilities, FY2023, at 2023-12-31$12.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043943.Report this figure9.7Current liabilities, Q1 FY2024, at 2024-03-31$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056265.Report this figure10.5Current liabilities, Q2 FY2024, at 2024-06-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093308.Report this figure14.7Current liabilities, Q3 FY2024, at 2024-09-30$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure14.9Current liabilities, FY2024, at 2024-12-31$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001193125-26-130401.Report this figure12.2Current liabilities, Q1 FY2025, at 2025-03-31$12.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure14.9Current liabilities, Q2 FY2025, at 2025-06-30$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure18.8Current liabilities, Q3 FY2025, at 2025-09-30$18.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure18.4Current liabilities, FY2025, at 2025-12-31$18.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure16.7Current liabilities, Q1 FY2026, at 2026-03-31$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure19.6Current liabilities, Q2 FY2026, at 2026-06-30$19.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Total liabilities$m28.0Total liabilities, Q3 FY2023, at 2023-09-30$28.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062097.Report this figure29.2Total liabilities, FY2023, at 2023-12-31$29.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0000950170-25-043943.Report this figure26.2Total liabilities, Q1 FY2024, at 2024-03-31$26.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056265.Report this figure26.8Total liabilities, Q2 FY2024, at 2024-06-30$26.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093308.Report this figure30.7Total liabilities, Q3 FY2024, at 2024-09-30$30.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure30.5Total liabilities, FY2024, at 2024-12-31$30.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-30, accession 0001193125-26-130401.Report this figure27.4Total liabilities, Q1 FY2025, at 2025-03-31$27.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure29.8Total liabilities, Q2 FY2025, at 2025-06-30$29.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure33.4Total liabilities, Q3 FY2025, at 2025-09-30$33.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure32.5Total liabilities, FY2025, at 2025-12-31$32.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure30.4Total liabilities, Q1 FY2026, at 2026-03-31$30.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure32.9Total liabilities, Q2 FY2026, at 2026-06-30$32.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure
Shareholders' equity$m152Shareholders' equity, Q3 FY2023, at 2023-09-30$151.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure226Shareholders' equity, FY2023, at 2023-12-31$225.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001193125-26-130401.Report this figure209Shareholders' equity, Q1 FY2024, at 2024-03-31$208.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure191Shareholders' equity, Q2 FY2024, at 2024-06-30$191.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure175Shareholders' equity, Q3 FY2024, at 2024-09-30$174.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure152Shareholders' equity, FY2024, at 2024-12-31$152.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure128Shareholders' equity, Q1 FY2025, at 2025-03-31$128.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure175Shareholders' equity, Q2 FY2025, at 2025-06-30$174.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure157Shareholders' equity, Q3 FY2025, at 2025-09-30$156.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure137Shareholders' equity, FY2025, at 2025-12-31$136.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure107Shareholders' equity, Q1 FY2026, at 2026-03-31$107.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure315Shareholders' equity, Q2 FY2026, at 2026-06-30$315.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure

Cash flow

Operating cash flow−$32.5m, Q2 FY2026
Capital expenditure$21.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(15.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$15.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125428. Derived: 9-month figure less the 6-month figure.Report this figure(17.4)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$17.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0000950170-25-043943. Derived: 12-month figure less the 9-month figure.Report this figure(24.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$24.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure(16.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001193125-25-179426. Derived: 6-month figure less the 3-month figure.Report this figure(15.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-278817. Derived: 9-month figure less the 6-month figure.Report this figure(24.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$24.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure(23.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(20.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$20.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343429. Derived: 6-month figure less the 3-month figure.Report this figure(20.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$20.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001193125-25-278817. Derived: 9-month figure less the 6-month figure.Report this figure(20.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$20.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure(29.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$29.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure(32.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$32.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343429. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$90.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125428. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$317.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-24, accession 0000950170-25-043943. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$88.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$525.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001193125-25-179426. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$341.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-278817. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2024, three months to 2024-12-31$299.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2025, three months to 2025-03-31$187.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$39.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343429. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$45.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001193125-25-278817. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$176.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001193125-26-130401. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$102.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343429. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)94.86m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares29.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3029,273,577 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062097.Report this figure37.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3137,784,282 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056265.Report this figure37.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3037,855,533 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-093308.Report this figure38.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3038,185,197 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125428.Report this figure49.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3149,451,943 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-071907.Report this figure49.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3049,548,120 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001193125-25-179426.Report this figure49.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3049,663,532 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure50.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3150,126,148 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure58.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3058,015,718 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure65.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3065,936,672 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001193125-25-278817.Report this figure67.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3167,447,576 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216808.Report this figure94.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3094,863,400 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure

Shares outstanding: 103.70mShares outstanding, period not labelled, at 2026-08-06103,704,809 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-343429.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.